Publicaciones en colaboración con investigadores/as de University Hospital Bonn (36)

2024

  1. Corrigendum to “European society of clinical microbiology and infectious diseases guidelines on diagnosis and treatment of brain abscess in children and adults” [Clin Microbiol and Infect 30(1) (2024 Jan) 66–89 Doi: 10.1016/j.cmi.2023.08.016] (Clinical Microbiology and Infection (2024) 30(1) (66–89), (S1198743X23003993), (10.1016/j.cmi.2023.08.016))

    Clinical Microbiology and Infection

  2. Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK

    Journal of Hospital Infection, Vol. 147, pp. 123-132

  3. European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults

    Clinical Microbiology and Infection

  4. “European Society of Clinical Microbiology and infectious Diseases Guidelines on diagnosis and treatment of brain abscess in children and adults” Author's reply

    Clinical Microbiology and Infection

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

    Transplantation, Vol. 107, Núm. 6, pp. 1330-1340

  3. Staphylococcus aureus surgical site infection rates in 5 European countries

    Antimicrobial Resistance and Infection Control, Vol. 12, Núm. 1

2022

  1. Coronary lithotripsy for the treatment of underexpanded stents: the international & multicentre CRUNCH registry

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 7, pp. 574-581

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

    Journal of Hepatology, Vol. 74, Núm. 5, pp. 1097-1108

  2. The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study

    Leukemia and Lymphoma

2020

  1. Characteristics and treatment regimens across ERS SHARP severe asthma registries

    European Respiratory Journal, Vol. 55, Núm. 1

  2. Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 4, pp. 963-973.e14

  3. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    Journal of Hepatology, Vol. 73, Núm. 4, pp. 842-854

2019

  1. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

    The Lancet, Vol. 393, Núm. 10167, pp. 143-155

  2. Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis

    Gastroenterology, Vol. 157, Núm. 1, pp. 149-162

  3. Intravascular Lithotripsy in Calcified Coronary Lesions: A Prospective, Observational, Multicenter Registry

    Circulation. Cardiovascular interventions, Vol. 12, Núm. 11, pp. e008154

  4. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248

  5. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656

2018

  1. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1